A certain type of white blood cell promotes the formation of metastases in breast cancer, according to researchers at the University of Fribourg, which says this discovery could be important for the development of new treatments.
This content was published on
3 minutes
Keystone-SDA
Português
pt
Pesquisadores suíços descobrem causa de metástases do câncer de mama
Although early detection and modern treatments offer most patients with breast cancer a good chance of recovery, around one in four of those affected develops metastases, the University of Fribourg wrote in a press release on Monday.
Metastatic cancer stem cells have the ability to break away from the original tumour and spread to other parts of the body, which promotes the spread of the cancer and makes treatment more difficult.
The development of metastases is promoted by inflammation inside the tumour and in its surroundings. The research team led by Curzio Rüegg has now identified a new mechanism that links this inflammation and the development of metastases. So-called granulocytes, a type of white blood cell that plays an important defence role in acute inflammation, facilitate the formation of metastases, the researchers showed in a study published in The Journal of Clinical Investigation.
“In a way, the cancer cells induce the granulocytes at the tumour site to produce inflammatory mediators, interleukin 6 and oncostatin,” Rüegg explained in the press release. In a second step, these two mediators then transform the breast cancer cells into a particularly aggressive form known as highly metastatic cancer stem cells.
In the study, the researchers showed in the laboratory that the inhibition of these two mediators suppresses the formation of cancer stem cells and metastases.
This work opens up real opportunities for the development of new treatments for patients with a high risk of metastasis, the university wrote. Interleukin-6 inhibitors are already available and are used to treat patients with chronic inflammatory diseases.
Translated from German by DeepL/ts
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.
If you want to know more about how we work, have a look here, and if you have feedback on this news story please write to english@swissinfo.ch.
Should raw milk sales be banned or should consumers decide?
Swiss food regulations do not allow raw milk to be sold for direct consumption. However, a loophole allows 400 raw milk vending machines to do just that.
Switzerland to step up humanitarian aid to Lebanon and Syria
This content was published on
The Swiss government decided to allocate an additional CHF7 million to the two countries in response to the escalating violence in the Middle East.
Report exposes widespread hygiene issues in Swiss hospitals
This content was published on
A Swissmedic report found that nearly all of the 25 Swiss hospitals inspected had issues with disinfecting, sterilising and packaging of medical products.
Swiss bank Mirabaud closes brokerage unit due to poor performance
This content was published on
The move spanning the bank’s global operations means a loss of 17 jobs, including five each in Switzerland and the UK, and seven in Spain.
Guterres condemns Israel’s plan to label UNRWA a terrorist organisation
This content was published on
UN Secretary-General Antonio Guterres has spoken out against a law proposed by the Israeli parliament that would classify UNRWA as a terrorist organisation.
This content was published on
The Swiss federal technology institute ETH Zurich is the best university in continental Europe, according to the Times Higher Education ranking.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.